HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
04 avr. 2024 07h30 HE
|
Avricore Health Inc.
Avriciore's HelathTab platform for point-of-care testing in pharmacy expands Rexall locations.
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
18 mars 2024 16h05 HE
|
Tenaya Therapeutics, Inc.
Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second Half of 2024 On Track to Dose First Patient in RIDGE™-1Phase 1b Clinical Trial of TN-401 for...
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
18 mars 2024 08h30 HE
|
Tenaya Therapeutics, Inc.
TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) PKP2 Gene Replacement Therapy Normalized Heart...
Global Cardiology IT Workflow Solutions Research Report 2024: Market to Reach $1.8 Billion by 2030 - Artificial Intelligence (AI) to Revolutionize Cardiology Workflow Management
01 mars 2024 06h16 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Cardiology IT Workflow Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cardiology IT...
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
27 févr. 2024 16h30 HE
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications
26 févr. 2024 08h30 HE
|
Tenaya Therapeutics, Inc.
Highly selective Small Molecule HDAC6 Inhibitor Effectively Reversed Heart Failure and Improved Diastolic Heart Function Alone or in Combination with SGLT2 Inhibitor in Murine Models of Disease ...
Artificial Intelligence in Cardiology Market Set for Rapid Growth, Forecast 2024-2034: Emphasis on Advanced Diagnostic Solutions with CAGR of 34.14%
29 janv. 2024 06h05 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence In Cardiology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
Cardiovascular Perfusion Disposables Market: Rapid Growth Forecast Revealed till 2033
24 janv. 2024 01h48 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Perfusion Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Service Credit Union Pledges to Donate $200,000 to First Responders in Campaign With Charlie McAvoy
23 janv. 2024 16h53 HE
|
Service Federal Credit Union
Service Credit Union has teamed up with Charlie McAvoy to donate $200,000 toward heart and cancer screenings for first responders.
Pediatric Perfusion Market Poised for Growth, Expected to Surpass USD 829 Million by 2030
20 déc. 2023 10h28 HE
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Perfusion Market Size, Share & Trends Analysis Report By Product (Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps), By...